{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:32:15Z","timestamp":1743726735018,"version":"3.40.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04127-9","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T18:14:17Z","timestamp":1743704057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The potential role of tranexamic acid and botulinum toxin in treating patients with acne vulgaris: a split face comparative study"],"prefix":"10.1007","volume":"317","author":[{"given":"Mohamed","family":"Metwalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina Ali","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5648-6842","authenticated-orcid":false,"given":"Reham","family":"Essam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"2","key":"4127_CR1","first-page":"1","volume":"6","author":"AK Mohiuddin","year":"2019","unstructured":"Mohiuddin AK (2019) A comprehensive review of acne vulgaris. Clin Res Dermatol Open Access 6(2):1\u201334","journal-title":"Clin Res Dermatol Open Access"},{"issue":"1","key":"4127_CR2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/bjaceaccp\/mku009","volume":"15","author":"MR Reed","year":"2015","unstructured":"Reed MR, Woolley LT (2015) Uses of Tranexamic acid. Continuing Edu Anaesth Crit Care Pain 15(1):32\u201337","journal-title":"Continuing Edu Anaesth Crit Care Pain"},{"key":"4127_CR3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.intimp.2018.12.031","volume":"67","author":"Y Li","year":"2019","unstructured":"Li Y, Xie H, Deng Z et al (2019) Tranexamic acid ameliorates rosacea symptoms by regulating immune response and angiogenesis. Int Immunopharmacol 67:326\u2013334","journal-title":"Int Immunopharmacol"},{"key":"4127_CR4","doi-asserted-by":"crossref","unstructured":"Rho NK, Gil YC (2021) Botulinum Neurotoxin Type A in the Treatment of Facial Seborrhea and Acne: Evidence and a Proposed Mechanism. Toxins (Basel). Nov 19;13(11):817","DOI":"10.3390\/toxins13110817"},{"issue":"7","key":"4127_CR5","doi-asserted-by":"crossref","first-page":"NP507","DOI":"10.1093\/asj\/sjac037","volume":"42","author":"L Birkett","year":"2022","unstructured":"Birkett L, Dhar S, Singh P, Mosahebi A (2022) Botulinum toxin a in the management of acne vulgaris: evidence and recommendations. Aesthetic Surg J 42(7):NP507\u2013NP509","journal-title":"Aesthetic Surg J"},{"issue":"7","key":"4127_CR6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00403-024-03143-5","volume":"316","author":"W Albalat","year":"2024","unstructured":"Albalat W, Ehab R et al (2024) Combined low-dose isotretinoin and long-pulsed Nd: YAG laser in the treatment of post-acne erythema. Arch Dermatol Res 316(7):359","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"4127_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2310\/7750.2007.00037","volume":"11","author":"JKL Tan","year":"2007","unstructured":"Tan JKL, Tang J, Fung K et al (2007) Development and validation of a comprehensive acne severity scale. J Cutan Med Surg 11(6):211\u2013216","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"4127_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2013.06.009","volume":"72","author":"ZJ Li","year":"2013","unstructured":"Li ZJ, Park SB, Sohn KC et al (2013) Regulation of lipid production by acetylcholine signaling in human sebaceous glands. J Dermatol Sci 72(2):116\u2013122","journal-title":"J Dermatol Sci"},{"issue":"9","key":"4127_CR9","first-page":"847","volume":"7","author":"AR Shah","year":"2008","unstructured":"Shah AR (2008) Use of intradermal botulinum toxin to reduce Sebum production and facial pore size. J Drugs Dermatol 7(9):847\u2013850 Accessed January 29, 2022","journal-title":"J Drugs Dermatol"},{"issue":"3 Pt 1","key":"4127_CR10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/dsu.12097","volume":"39","author":"AE Rose","year":"2013","unstructured":"Rose AE, Goldberg DJ (2013) Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin. Dermatol Surg 39(3 Pt 1):443\u2013448","journal-title":"Dermatol Surg"},{"issue":"1","key":"4127_CR11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/DSS.0000000000002494","volume":"47","author":"K Kesty","year":"2021","unstructured":"Kesty K, Goldberg DJ (2021) A randomized, double-blinded study evaluating the safety and efficacy of abobotulinumtoxin A injections for oily skin of the forehead: a dose-response analysis. Dermatol Surg 47(1):56\u201360","journal-title":"Dermatol Surg"},{"issue":"10","key":"4127_CR12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/ijd.15574","volume":"60","author":"M Shirshakova","year":"2021","unstructured":"Shirshakova M, Morozova E et al (2021) The effectiveness of botulinum toxin type A (BTX-A) in the treatment of facial skin oily seborrhea, enlarged pores, and symptom complex of post-acne. Int J Dermatol 60(10):1232\u20131241","journal-title":"Int J Dermatol"},{"issue":"5","key":"4127_CR13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/asj\/sju150","volume":"35","author":"P Min","year":"2015","unstructured":"Min P, Xi W, Grassetti L et al (2015) Sebum production alteration after botulinum toxin types A injections for the treatment of forehead rhytides: a prospective randomized double-blind dose-comparative clinical investigation. Aesthet Surg J 35(5):600\u2013610","journal-title":"Aesthet Surg J"},{"key":"4127_CR14","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1111\/jocd.14692","volume":"21","author":"L Calvisi","year":"2022","unstructured":"Calvisi L, Diaspro A, Sito G (2022) Microbotox: A prospective evaluation of dermatological improvement in patients with mild-to-moderate acne and erythematotelangiectatic rosacea. J Cosmet Dermatol 21:3747\u20133753","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"4127_CR15","first-page":"42","volume":"14","author":"A Luque","year":"2021","unstructured":"Luque A, Rojas AP et al (2021) Botulinum toxin: an effective treatment for Flushing and persistent erythema in rosacea. J Clin Aesthetic Dermatol 14(3):42","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"1","key":"4127_CR16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jdermsci.2017.05.019","volume":"88","author":"YH Cho","year":"2017","unstructured":"Cho YH, Park JE et al (2017) Tranexamic acid inhibits melanogenesis by activating the autophagy system in cultured melanoma cells. J Dermatol Sci 88(1):96\u2013102","journal-title":"J Dermatol Sci"},{"key":"4127_CR17","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1111\/jocd.14972","volume":"21","author":"A Charoenwattanayothin","year":"2022","unstructured":"Charoenwattanayothin A, Saiwichai T, Chaichalotornkul S (2022) Adjunctive treatment for acne vulgaris by Tranexamic acid. J Cosmet Dermatol 21:4515\u20134522","journal-title":"J Cosmet Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04127-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04127-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04127-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T18:15:15Z","timestamp":1743704115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04127-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4127"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04127-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The Institutional Review Board (ZU-IRB #10318) reviewed and approved the study at the Faculty of Medicine, Zagazig University.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}},{"value":"The authors obtained consent for the publication of identifiable material. All patients gave consent with the understanding that this information may be publicly available.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"The patient consent statement"}}],"article-number":"657"}}